News & Events :: SCYNEXIS, Inc. (SCYX)

Skip to main content Skip to section navigation Skip to footer

Recent News

Dec 22, 2025 8:00am EST

SCYNEXIS Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

Nov 19, 2025 7:00am EST

SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK

Latest Presentation

View All Presentations

Nov 6, 2025

Investor Presentation

View All Presentations

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings